Associate Professor, Medicine, USC School of Medicine
Hematology
Dr. Vinod Pullarkat, MD
|
|
Give Review
Dr. Vinod Pullarkat practices Hematology. He graduated from Medical College and Hospital Kolkata. Vinod Pullarkat is also a published physician. He has 66 paper published. The most recent paper is: Skin metastases: an unusual presenting sign of gastric carcinoma. He is registered with Medicare and accepts Medicare payments.
Publications
- Improving erythropoiesis: a compelling case for iron chelation in myelofibrosis.
- Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.
- Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
- Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome.
- Prognostic and therapeutic implications of early treatment response assessment in Acute myeloid leukemia.
- AutoImmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature.
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis.
- Iron chelators induce autophagic cell death in multiple Myeloma cells.
- A shortened activated partial thromboplastin time predicts the risk of catheter-associated venous thrombosis in Cancer patients.
- Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia.
- Nodular Regenerative Hyperplasia Causing Portal Hypertension in a Patient with Chronic Graft versus Host Disease: Response to Sirolimus.
- Iron Toxicity in Hematopoietic Stem Cell Transplantation: Strike while the Iron Is Labile.
- An effective reinduction regimen for first relapse of adult Acute lymphoblastic leukemia.
- The Combination of Fludarabine, Cytarabine and Etoposide Is an Active and Well-Tolerated Regimen in Relapsed/Refractory Acute Myeloid Leukemia.
- Characterization of bone marrow mast cells in Acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
- Therapy-related Acute myeloid leukemia with favorable cytogenetics: Still favorable?
- Major non-ABO incompatibility caused by anti-Jk(a) in a patient before allogeneic hematopoietic stem cell transplantation.
- Deferasirox: appraisal of safety and efficacy in long-term therapy.
- Detection of lupus anticoagulant identifies patients with autoImmune haemolytic anaemia at increased risk for venous thromboembolism.
- Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells.
- Distinct clonal origins of systemic mastocytosis and associated B-cell Lymphoma.
- Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic Myeloid sarcoma of the uterus.
- Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis.
- Neoplastic mast cells in systemic mastocytosis associated with t(8;21) Acute myeloid leukemia are derived from the leukemic clone.
- A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplant...
- Efficacy of mycophenolate mofetil in the treatment of Chronic graft-versus-host disease.
- A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.
- Gene polymorphisms associated with diminished activity of 5,10-methylenetetrahydrofolate reductase do not explain the clinical manifestations of cobalamin deficiency.
- Primary autoImmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
- The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- Acute lymphoblastic leukemia cells.
- Impact of Graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associate...
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-contr...
- Efficacy of romiplostim in patients with Chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
- Impact of cytogenetics on the outcome of adult Acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study.
- Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections.
- CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.
- A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
- Improved outcomes using tacrolimus/sirolimus for Graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell ...
- Objectives of iron chelation therapy in Myelodysplastic syndromes: more than meets the eye?
- Systemic mastocytosis associated with t(8;21)(q22;q22) Acute myeloid leukemia.
- Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with Chronic ITP.
- Iron overload in patients undergoing hematopoietic stem cell transplantation.
- Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's Lymphoma and mantle cell Lymphoma.
- Diagnosis and management of Immune thrombocytopenia in the era of thrombopoietin mimetics.
- Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.
- Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCT.
- Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk Leukemia.
- Nontyphoidal Salmonella infection among recipients of hematopoietic SCT.
- Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
- Quantifying the reduction in immunoglobulin use over time in patients with Chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).
- Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation.
- Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on ch...
- Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable Disease control in myel...
- Immunotherapy with Acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods.
- Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atheroThrombosis.
- Transduction of Acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, different...
- Body cavity-based presentation of natural killer cell Lymphoma.
- Systemic mastocytosis with associated clonal hematological non-mast-cell lineage Disease: analysis of clinicopathologic features and activating c-kit mutations.
- Pathology of autoImmune myelofibrosis. A report of three cases and a review of the literature.
- Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis.
- Mast cell disease associated with Acute myeloid leukemia: detection of a new c-kit mutation Asp816His.
- Ticlopidine-induced aplastic Anemia: development of chromosomal abnormalities and response to immunosuppressive therapy.
- Intraspinal hemorrhage complicating oral anticoagulant therapy: an unusual case of cervical hematomyelia and a review of the literature.
- A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast Cancer that overexpresses HER2/neu.
- Skin metastases: an unusual presenting sign of gastric carcinoma.
Schools
Calicut Medical College University Of Calicut
Calicut Mc
Ny Meth Hospital
University So Calif
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Medicare Advantage PFFS
- Medicare MCR
Education
-
University of Southern California - LAC+USC Medical Center -
New York Methodist Hospital -
Medical College and Hospital Kolkata
Hospital
-
Keck Hospital of USC
Drug Facts
| NPI NUMBER | 1164433645 | |
| NPPES Provider LastName | PULLARKAT | |
| NPPES Provider FirstName | VINOD | |
| NPPES Provider ZIPCode | 900890112 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 195.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164433645 |
| Last Name Of The Provider | PULLARKAT |
| First Name Of The Provider | VINOD |
| View All |
Similar Doctors
|
Dr. Jason S. Ho, MD |
|
|
Dr. Eduardo O. Lim, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melani P. Shaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christy A. Russell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald I. Feinstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cage S. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasanth K. Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Halline U. Overby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sang-Hoon Ahn, MD |
|
|
Dr. Lisa Altman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen B. Bredt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol J. Hanna, MD |
|
|
Dr. Frank J. Latino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilene C. Weitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alex Y. Kawana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David I. Quinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Shin, MD |
|
|
Dr. Victoria A. Forte, MD |
|
|
Dr. Jennifer L. Malin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. McDonnell, MD |
|
|
Linda Markarian, PA-C |
|
|
Denise K. Oseguera, NP
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarmad Sadeghi, MD
This Doctor is OpenDoctor Recommended.
|